We used CD4 T data to select four genes, HSPH1, ATF3, NDUFB3 and HIST1H1E, to construct a risk score model for judging the prognosis, which may guide the clinical treatment of ESCC. The gene discussed is NDUFB3; the disease is esophageal squamous cell carcinoma.